pyrrolidine dithiocarbamate has been researched along with Break-Bone Fever in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Mon, M; Duran, A; Fuenmayor, E; Mosquera, J; Valero, N | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Break-Bone Fever
| Article | Year |
|---|---|
Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures.
Topics: Adult; Animals; Antiviral Agents; Cell Line; Cells, Cultured; Culicidae; Cytokines; Dengue; Dengue Virus; ErbB Receptors; Gefitinib; Humans; Male; Monocytes; NF-kappa B; Nod2 Signaling Adaptor Protein; Protein Kinase Inhibitors; Pyrrolidines; Quinazolines; Thiocarbamates; Virus Replication | 2017 |